| Sign In | Join Free | My benadorassociates.com |
|
| Categories | Vacuum Blood Test Tube |
|---|---|
| Brand Name: | Orsin |
| Model Number: | Gel Clot ActivatoR |
| Certification: | ISO 13485 |
| Place of Origin: | China |
| MOQ: | 100/pcs |
| Price: | Negotiation |
| Payment Terms: | L/C, D/A, D/P, T/T, Western Union |
| Supply Ability: | 20million/pcs/moth |
| Delivery Time: | 1-4 weeks |
| Product Nam: | EDTA K2/K3 |
| Tube Diameter: | 13 × 75mm |
| Storage Condition: | Room Temperature |
| Tube Label: | White Label |
| Logo Printing: | Available for big orders (>30000 PCS) |
| Company Visits: | Welcome to visit company and factory |
| Inner Wall Treatment: | Bionic active membrane |
| Tube Cap Type: | Screw Cap |
| Volume: | 3ml |
| Feature: | prevention of platelet aggregation |
| Production Experience: | 3 years |
| Tube Type: | Round Bottom |
| Company Info. |
| Shanghai Orsin Medical Technology Co., Ltd. |
| Verified Supplier |
| View Contact Details |
| Product List |
The EDTA K2 blood collection tube, containing dipotassium ethylenediaminetetraacetic acid (EDTA-K₂) as an anticoagulant, functions by chelating calcium ions in blood to inhibit the coagulation cascade, thereby preserving the original morphology of blood cells ex vivo. Its clinical roles and significance include:
Gold Standard for Hematology Testing: As the preferred anticoagulant for complete blood count (CBC), genetic mutation detection,and lood smear examinations, it ensures accuracy in white blood cell differentials, red cell morphology, and prevention of platelet aggregation.
Cellular Stability Maintenance: EDTA-K₂ prevents platelet aggregation and minimizes cell lysis, making it critical for assays requiring intact cells (e.g., flow cytometry for CD4/CD8 counts);
Standardized Laboratory Practice: Recommended by the International Council for Standardization in Haematology (ICSH) for routine hematology testing, ensuring result comparability and reliability;
Diagnostic Value: Provides essential data for screening, diagnosing, and monitoring conditions such as anemia, infections, hematologic malignancies (e.g., leukemia), and thrombotic disorders.
Note: Gently invert the tube 8-10 times post-collection; samples should be analyzed within 4 hours to prevent cellular degradation affecting results.
|